Home Health Care Nursing Unit, Division of Ambulatory Care Nursing Service, Department of Nursing, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Ramathibodi School of Nursing, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Nutrition. 2018 Feb;46:1-6. doi: 10.1016/j.nut.2017.08.002. Epub 2017 Aug 7.
The aim of this study was to determine the incidence and predictive factors of catheter-related bloodstream infections (CRBSIs) acquired through a central venous catheter for delivery of home parenteral nutrition (HPN) therapy among a patient population in Thailand.
This retrospective review was conducted with adult patients with intestinal failure who received HPN from October 2002 to April 2014, at Ramathibodi Home Parenteral and Enteral Nutrition Referral Center in Bangkok.
Seventy-two patients (45.8% male, mean age 56.2 ± 15.7 y) were included in the analysis. Incidence of CRBSIs was 1.47 per 1000 catheter days. Over the 12-y period, there were 21 CRBSIs among 10 patients. There were 26 pathogens isolated from these CRBSIs, mostly coagulase-negative staphylococci. Univariate Poisson regression analysis revealed that the incidence rate ratio of CRBSIs was significantly higher in patients who used an implanted port (compared with tunneled catheter), alcohol-based povidone-iodine solution as disinfectant (compared with 2% chlorhexidine gluconate in 70% isopropyl alcohol), cyclic HPN infusion (compared with continuous HPN), and hospital-based compound HPN formulations (compared with 3-in-1 commercial formulations). Furthermore, longer duration of HPN (>250 d) was associated with CRBSIs. Multivariate analysis revealed that longer duration of HPN, cyclic HPN, and hospital-based compound HPN were significantly associated with CRBSIs.
CRBSI is a significant complication in patients receiving long-term HPN. Individualized therapy with a multidisciplinary team in centers with HPN management expertise is required. Careful selection of the catheter type and HPN formulation for each patient is necessary to best meet patient requirements and minimize HPN-related complications. Strict compliance by patients and caregivers with evidence-based instructions together with supervision by well-trained HPN providers is the most effective strategy to prevent CRBSIs.
本研究旨在确定泰国接受家庭肠外营养(HPN)治疗的患者中,因中心静脉导管(CVC)而发生的导管相关性血流感染(CRBSI)的发生率和预测因素。
本回顾性研究纳入了 2002 年 10 月至 2014 年 4 月期间在曼谷 Ramathibodi 家庭肠外和肠内营养转诊中心接受 HPN 治疗的成年肠衰竭患者。
72 例患者(45.8%为男性,平均年龄 56.2±15.7 岁)纳入分析。CRBSI 的发生率为 1.47/1000 导管日。在 12 年期间,10 名患者中有 21 例发生 CRBSI。从这些 CRBSI 中分离出 26 种病原体,主要为凝固酶阴性葡萄球菌。单变量泊松回归分析显示,与隧道式导管相比,使用植入式端口、酒精基聚维酮碘溶液作为消毒剂(与 70%异丙醇中 2%洗必泰相比)、周期性 HPN 输注(与连续性 HPN 相比)以及基于医院的复合 HPN 配方(与 3-in-1 商业配方相比)的患者,CRBSI 的发生率更高。此外,HPN 时间较长(>250 天)与 CRBSI 相关。多变量分析显示,HPN 时间较长、周期性 HPN 和基于医院的复合 HPN 与 CRBSI 显著相关。
CRBSI 是接受长期 HPN 治疗的患者的严重并发症。需要在具有 HPN 管理专业知识的中心由多学科团队进行个体化治疗。为每个患者选择合适的导管类型和 HPN 配方以满足患者需求并最大限度减少 HPN 相关并发症非常重要。患者和护理人员严格遵守基于证据的指导方针并接受经过良好培训的 HPN 提供者的监督是预防 CRBSI 的最有效策略。